IEQ Capital’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Sell
128,792
-58,935
-31% -$190K ﹤0.01% 1445
2026
Q1
$541K Sell
187,727
-48,965
-21% -$193K ﹤0.01% 1271
2025
Q4
$963K Sell
236,692
-3,183
-1% -$14.3K ﹤0.01% 1060
2025
Q3
$852K Buy
239,875
+226
+0.1% +$817 ﹤0.01% 1071
2025
Q2
$654K Buy
239,649
+134,817
+129% +$278K ﹤0.01% 1030
2025
Q1
$176K Buy
104,832
+85,004
+429% +$238K ﹤0.01% 1404
2024
Q4
$32.3K Buy
+19,828
New +$59.1K ﹤0.01% 1306

Other funds holding SANA

IEQ Capital's SANA Position: Q2 2026 in Review

IEQ Capital reduced its Sana Biotechnology (SANA) stake by 31% in Q2 2026, selling an estimated $190K and leaving 128,792 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

IEQ Capital first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $963K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • IEQ Capital held 128,792 shares of Sana Biotechnology worth $449K as of Q2 2026.
  • IEQ Capital sold 58,935 Sana Biotechnology shares in Q2 2026, an estimated $190K.
  • Sana Biotechnology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1445 holding.
  • IEQ Capital first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • IEQ Capital's Sana Biotechnology position peaked at $963K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.